| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC0363 |
| Trial ID | NCT03090659 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | LCAR-B38M |
| Phase | Phase1|Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | LCAR-B38M Cells in Treating Relapsed/Refractory (R/R) Multiple Myeloma |
| Year | 2017 |
| Country | China |
| Company sponsor | Nanjing Legend Biotech Co. |
| Other ID(s) | LCAR-B38M |
| Cohort 1 | |||||||||||||
|
|||||||||||||